{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T09:34:13Z","timestamp":1774085653319,"version":"3.50.1"},"reference-count":21,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2018,10,9]],"date-time":"2018-10-09T00:00:00Z","timestamp":1539043200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA138627"],"award-info":[{"award-number":["R01 CA138627"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 CA054174"],"award-info":[{"award-number":["P30 CA054174"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA179115"],"award-info":[{"award-number":["R01 CA179115"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0204823","type":"journal-article","created":{"date-parts":[[2018,10,9]],"date-time":"2018-10-09T13:42:00Z","timestamp":1539092520000},"page":"e0204823","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":13,"title":["The effect of 3-month finasteride challenge on biomarkers for predicting cancer outcome on biopsy: Results of a randomized trial"],"prefix":"10.1371","volume":"13","author":[{"given":"Javier","family":"Hernandez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Gelfond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Goros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A.","family":"Liss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanyuan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donna","family":"Ankerst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian M.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3201-5579","authenticated-orcid":true,"given":"Robin J.","family":"Leach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2018,10,9]]},"reference":[{"issue":"22","key":"ref1","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1056\/NEJMoa031918","article-title":"Prevalence of prostate cancer among men with a prostate-specific antigen level\u2264 4.0 ng per milliliter.","volume":"350","author":"IM Thompson","year":"2004","journal-title":"New England Journal of Medicine"},{"issue":"13","key":"ref2","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1056\/NEJMoa0810084","article-title":"Screening and prostate-cancer mortality in a randomized European study","volume":"360","author":"FH Schroder","year":"2009","journal-title":"The New England journal of medicine"},{"issue":"5","key":"ref3","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/S0090-4295(02)01958-1","article-title":"Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program","volume":"60","author":"R Raaijmakers","year":"2002","journal-title":"Urology"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"d7894","DOI":"10.1136\/bmj.d7894","article-title":"Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study","volume":"344","author":"DJ Rosario","year":"2012","journal-title":"Bmj"},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1093\/jnci\/dju366","article-title":"Cost-effectiveness of prostate cancer screening: a simulation study based on ERSPC data","volume":"107","author":"EA Heijnsdijk","year":"2015","journal-title":"Journal of the National Cancer Institute"},{"issue":"2","key":"ref6","doi-asserted-by":"crossref","first-page":"120","DOI":"10.7326\/0003-4819-157-2-201207170-00459","article-title":"Force USPST. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement","volume":"157","author":"VA Moyer","year":"2012","journal-title":"Annals of internal medicine"},{"issue":"4","key":"ref7","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.juro.2008.06.038","article-title":"Predicting prostate cancer risk through incorporation of prostate cancer gene 3","volume":"180","author":"DP Ankerst","year":"2008","journal-title":"The Journal of urology"},{"issue":"31","key":"ref8","doi-asserted-by":"crossref","first-page":"4596","DOI":"10.1038\/sj.onc.1210237","article-title":"TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort","volume":"26","author":"F Demichelis","year":"2007","journal-title":"Oncogene"},{"issue":"16","key":"ref9","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1093\/jnci\/djj307","article-title":"Effect of finasteride on the sensitivity of PSA for detecting prostate cancer","volume":"98","author":"IM Thompson","year":"2006","journal-title":"Journal of the National Cancer Institute"},{"issue":"5","key":"ref10","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/S0022-5347(05)00984-5","article-title":"Clinical usefulness of serum prostate specific antigen for the detection of prostate cancer is preserved in men receiving the dual 5alpha-reductase inhibitor dutasteride","volume":"175","author":"GL Andriole","year":"2006","journal-title":"The Journal of urology"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/pros.2990220105","article-title":"The effect of finasteride on prostate-specific antigen in men with benign prostatic hyperplasia","volume":"22","author":"HA Guess","year":"1993","journal-title":"The Prostate"},{"issue":"6","key":"ref12","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.urology.2006.08.1070","article-title":"Can effect of finasteride on prostate-specific antigen be used to decrease repeat prostate biopsy","volume":"68","author":"LN Handel","year":"2006","journal-title":"Urology"},{"issue":"3","key":"ref13","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S0090-4295(02)01760-0","article-title":"PSA response to finasteride challenge in men with a serum PSA greater than 4 ng\/ml and previous negative prostate biopsy: preliminary study","volume":"60","author":"SA Kaplan","year":"2002","journal-title":"Urology"},{"issue":"1B","key":"ref14","first-page":"693","article-title":"Early diagnosis of prostate cancer in finasteride treated BPH patients","volume":"23","author":"M Tarle","year":"2003","journal-title":"Anticancer research"},{"issue":"5","key":"ref15","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.eururo.2008.06.071","article-title":"Clinical utility of the PCA3 urine assay in European men scheduled for repeat biopsy","volume":"54","author":"A Haese","year":"2008","journal-title":"European urology"},{"issue":"5","key":"ref16","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.eururo.2011.08.003","article-title":"Contemporary role of prostate cancer antigen 3 in the management of prostate cancer","volume":"60","author":"M Auprich","year":"2011","journal-title":"European urology"},{"issue":"4","key":"ref17","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.eururo.2010.06.039","article-title":"Performance of the prostate cancer antigen 3 (PCA3) gene and prostate-specific antigen in prescreened men: exploring the value of PCA3 for a first-line diagnostic test","volume":"58","author":"MJ Roobol","year":"2010","journal-title":"European urology"},{"issue":"3","key":"ref18","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.urology.2006.12.014","article-title":"PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy","volume":"69","author":"LS Marks","year":"2007","journal-title":"Urology"},{"issue":"4","key":"ref19","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.juro.2007.11.038","article-title":"PCA3: a molecular urine assay for predicting prostate biopsy outcome","volume":"179","author":"IL Deras","year":"2008","journal-title":"The Journal of urology"},{"issue":"5","key":"ref20","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/j.1464-410X.2011.10875.x","article-title":"Effect of treatment with 5-alpha reductase inhibitors on progression in monitored men with favourable-risk prostate cancer","volume":"110","author":"AE Ross","year":"2012","journal-title":"BJU international"},{"issue":"9821","key":"ref21","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/S0140-6736(11)61619-X","article-title":"Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trial","volume":"379","author":"NE Fleshner","year":"2012","journal-title":"Lancet"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0204823","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T02:38:14Z","timestamp":1540262294000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0204823"}},"subtitle":[],"editor":[{"given":"David J.","family":"Handelsman","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,10,9]]},"references-count":21,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2018,10,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0204823","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,9]]}}}